The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

Background. Identification of predictive molecular markers of triple-negative breast cancer (TNBC) will enable the evaluation of the efficacy of neoadjuvant chemotherapy (NACT) and define optimum approaches for the prognosis of the disease course in TNBC patients.The aim of the study was to examine...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva
Format: Artigo
Idioma:Inglês
Publicat: Siberian State Medical University (Tomsk) 2020-04-01
Col·lecció:Bûlleten' Sibirskoj Mediciny
Matèries:
triple-negative breast cancer
neoadjuvant chemotherapy
epidermal growth factor receptor (egfr)
gene polymorphisms
Accés en línia:https://bulletin.tomsk.ru/jour/article/view/2675
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars